Urology · Laguna Hills, CA
NPI
1063626893
Since 2007
Specialty
Urology
Code 2088F0040X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
23961 Calle de la Magdalena Ste 500
Laguna Hills, CA, 92653
Phone (949) 855-1011
Groups this clinician bills Medicare through
Medicare paid, 2024
$340K
15,580 services
Medicare patients, 2024
910
Average age 77
Drug cost, 2024
$1.1M
4,369 prescriptions
Company payments, 2025
$2,969
From 16 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Leah Y Nakamura was code J0585 (injection, onabotulinumtoxina, 1 unit), 3,600 times for 18 patients. In total Leah Y Nakamura billed 15,580 services in 89 codes, and Medicare paid $340K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-10-22.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0585 Injection, onabotulinumtoxina, 1 unit | Office | 3,600 | 18 | $4.98 | $18K |
| J1644 Injection, heparin sodium, per 1000 units | Office | 3,520 | 19 | $0.19 | $681 |
| 81003 Clinical Chemistry | Office | 1,476 | 764 | $2.20 | $3,247 |
| 99214 Office E&M - Established | Office | 771 | 489 | $110.58 | $85K |
| 51798 Ultrasound - Nonspecific | Office | 753 | 522 | $10.52 | $7,922 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 586 | 430 | $14.56 | $8,533 |
| 99213 Office E&M - Established | Office | 538 | 389 | $76.01 | $41K |
| 99459 Office/Outpatient Services | Office | 423 | 326 | $21.44 | $9,071 |
| 99211 Office E&M - Established | Office | 272 | 79 | $21.81 | $5,932 |
| 99204 Office E&M - New | Office | 241 | 241 | $141.17 | $34K |
| 51700 Other Organ Systems | Office | 121 | 30 | $71.29 | $8,626 |
| 52000 Cystourethroscopy | Office | 101 | 94 | $215.34 | $22K |
| 64566 Musculoskeletal | Office | 99 | 11 | $111.00 | $11K |
| 52287 Cystourethroscopy | Office | 30 | 18 | $360.95 | $11K |
| 99232 Hospital E&M - Subsequent | Facility | 29 | 22 | $70.24 | $2,037 |
By year: 2022 $255K for 8,249 services; 2023 $303K for 14,637 services; 2024 $340K for 15,580 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 81003 Clinical Chemistry | 1,476 | 764 | $2.20 | $3,247 |
| P9612 Catheterization for collection of specimen, single patient, all places of service | 18 | 17 | $5.88 | $106 |
| 88108 Surgical Pathology Examination | 13 | 13 | $43.59 | $567 |
Medicare prescription drug claims, 2024
In 2024, the drug Leah Y Nakamura prescribed most often to Medicare patients was Gemtesa (Vibegron), with 756 prescriptions and refills. In total Leah Y Nakamura wrote 4,369 Medicare prescriptions that cost $1.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Gemtesa Vibegron | 756 | 1,407 | 211 | $658K |
| Estradiol Generic | 592 | 1,812 | 372 | $42K |
| Methenamine Hippurate Generic | 376 | 806 | 146 | $35K |
| Nitrofurantoin Mono-Macro Nitrofurantoin Monohyd/M-Cryst | 337 | 343 | 257 | $3,518 |
| Myrbetriq Mirabegron | 233 | 421 | 72 | $186K |
| Nitrofurantoin Nitrofurantoin Macrocrystal | 213 | 512 | 94 | $9,556 |
| Amoxicillin-Clavulanate Potass Amoxicillin/Potassium Clav | 155 | 155 | 119 | $850 |
| Cephalexin Generic | 154 | 361 | 71 | $2,031 |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 134 | 134 | 125 | $336 |
| Premarin Estrogens, Conjugated | 127 | 346 | 71 | $55K |
| Tamsulosin Hcl Generic | 120 | 295 | 48 | $1,791 |
| Trospium Chloride Generic | 110 | 195 | 44 | $6,678 |
| Ciprofloxacin Hcl Generic | 90 | 90 | 69 | $361 |
| Cefuroxime Cefuroxime Axetil | 82 | 82 | 62 | $969 |
| Cefdinir Generic | 82 | 91 | 58 | $1,258 |
Brand drugs: - claims; generic drugs: 3,119 claims; opioid claims: 91.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Leah Y Nakamura $2,969 ($2,969 in general payments such as food, travel and fees) from 16 companies. The largest payer was Medtronic, Inc. with $1,546.
| Company | Payments | Amount |
|---|---|---|
| Medtronic, Inc. MDT | 25 | $1,546 |
| FEMSelect Inc. | 4 | $228 |
| Abbvie Inc. ABBV | 8 | $208 |
| Sumitomo Pharma America, Inc. 4506.T | 4 | $187 |
| Boston Scientific Corporation BSX | 2 | $171 |
| Bluewind Medical | 7 | $161 |
| Calyxo, Inc. | 2 | $145 |
| Merck Sharp & Dohme LLC MRK | 2 | $52.66 |
| Urogen Pharma, Inc. URGN | 1 | $45.3 |
| C. R. Bard, Inc. & Subsidiaries BDX | 1 | $42.25 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.